felinta 15 mg retardtabletten für katzen
felinta 10 mg retardtabletten für katzen
felinta 10 mg prolonged-release tablets for cats
milstein c.v. - carbimazole - prolonged-release tablet - anti hormone agent - cats
felinta 15 mg prolonged-release tablets for cats
milstein c.v. - carbimazole - prolonged-release tablet - anti hormone agent - cats
nobivac ducat
intervet ireland limited - feline calicivrus, strain f9 live attenuated, felint rhinotracheitis virus - lyophilisate and solvent for suspension for injection - unknown - feline rhinotracheitis virus vaccine + feline calicivirus vaccine - feline - immunological - live vaccine
leucofeligen felv/rcp formulation: each dose contains: feline rhinotracheitis virus (f2 strain).....104.6-6.1 ccid 50 feline calicivirus (f9 strain).......105-6.6 ccid 50 feline panleukopenia virus (lr 72 strain).....103.7-4.5 ccid 50 feline leukemia virus (p-45 enveloped antigen)....≥102 μg . ccid - cell culture infectious dose freeze-dried pellet for suspension for injection (sc)
virbac philippines inc.; distributor: virbac philippines inc. - modified live feline rhinotracheitis virus (fvr) , feline calicivirus (fcv) , feline panleukopenia virus (fpv) , feline leukemia virus (felv) antigen. vaccine (vet.) - freeze-dried pellet for suspension for injection (sc) - formulation: each dose contains: feline rhinotracheitis virus (f2 strain).....104.6-6.1 ccid 50 feline calicivirus (f9 strain).......105-6.6 ccid 50 feline panleukopenia virus (lr 72 strain).....103.7-4.5 ccid 50 feline leukemia virus (p-45 enveloped antigen)....≥102 μg . ccid - cell culture infectious dose
purevax felv
boehringer ingelheim vetmedica gmbh - feline leukaemia virus recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats of 8 weeks of age or older against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.onset of immunity has been demonstrated 2 weeks after primary vaccination course.the duration of immunity is one year after the last vaccination.
companion felv vaccine against feline leukaemia virus (felv)
intervet australia pty limited - aluminium hydroxide; quil-a; recombinant gp70 sub-type a - misc. vaccines or anti sera - aluminium hydroxide mineral-aluminium-base active 3.0 mg/do; quil-a plant active 10.0 ug/do; recombinant gp70 sub-type a vaccine-antigen/antibody active 102.0 ug/do - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | disease caused by
nobivac hcp+felv formulation: each 1 ml (dose) contains: feline rhinotracheitis virus (593-j strain) .............>10^4.7 pfu feline calicivirus (894-t strain) > 10^3.1 pfu feline panleukopenia ......................... >10^3 faid50 feline leukemia virus (rickard isolate).................. >1.3 rp pfu - plaque forming unit faid - fluorescent antibody infectious dose rp - relative potency freeze-dried powder for injection (im/sc)
msd animal health (phils.), inc. - modified live feline rhinotracheitis virus (fvr) , feline calicivirus (fcv) , feline panleukopenia (fpl) , killed feline leukemia virus (felv) vaccine (vet.) - freeze-dried powder for injection (im/sc) - formulation: each 1 ml (dose) contains: feline rhinotracheitis virus (593-j strain) .............>10^4.7 pfu feline calicivirus (894-t strain) > 10^3.1 pfu feline panleukopenia ......................... >10^3 faid50 feline leukemia virus (rickard isolate).................. >1.3 rp pfu - plaque forming unit faid - fluorescent antibody infectious dose rp - relative potency
leucogen
virbac s.a. - feline leukemia virus envelope antigen p45 - suspension for injection - %v/v - feline leukaemia virus vaccine - feline - immunological - inactivated vaccine